Enrolling Clinical Studies
PCR, Inc., welcomes a new Principal Investigator!

Phyllis Ritchie, M.D.
Board Certified Internal Medicine & Infectious Diseases
CEO & Founder of PS...Test
Infectious Disease Protocol Principal Investigator
Dr. Ritchie is a Board Certified Internal Medicine & Infectious Disease physician who has lived & worked in Palm Springs, CA for the past 10 years.
Dr. Ritchie's work with non-profit organizations include Desert AIDS Project (DAP) and is currently the CEO & Founder of PS...Test, the first FREE clinic in Riverside County to test and treat sexually transmitted infections (STI's).
Visit https://healthypstest.org to learn more.
Dr. Ritchie & PCR, Inc. are currently conducting clinical trials in HIV & Gonorrhea.
Enrolling Clinical Trials
Alopecia Areata (AA) Clinical Trial
Alopecia is an autoimmune disease that causes hair loss on the scalp, face, and other parts of the body. This condition affects males & females of all ages. Different types include: Alopecia Areata - patchy hair loss; Alopecia Totalis - complete hair loss on the scalp; Alopecia Universalis - complete hair loss on the scalp and body; and Alopecia Ophiasis - hair loss on the occipital (posterior scalp), temporal (temples), and parietal (area in front & behind the ears) areas of the scalp.
Symptoms include:
- Patchy hair loss on the scalp
- Complete hair loss on the scalp
- Complete hair loss on the scalp & body
You may qualify for this no-cost clinical trial if you:
- Are 18 - 65 years of age
- Have moderate to severe Alopecia
- 50% or more hair loss on the scalp
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Sign up with the National Alopecia Areata Foundation to learn more about this condition at https://www.naaf.org/alopecia-areata
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
COPD is a chronic inflammatory lung disease which causes obstructed airflow from the lungs. COPD is most often caused from a smoking history and may increase your risk of heart disease and lung cancer.
Symptoms include:
- Breathing difficulty/Shortness of breath
- Coughing/Wheezing
- Chest tightness
- Sputum (mucus) production
You may qualify for this no-cost clinical trial if you:
- Are 40 - 85 years of age
- Have moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
- History of 2 moderate or 1 severe COPD exacerbations in the previous 12 months
- Use of triple (ICS/LABA/LAMA) therapy for COPD
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Bronchiectasis Clinical Trial
Bronchiectasis is a chronic inflammatory disease where the walls of the bronchi are thickened from inflammation & infection. Patients suffer from daily cough and sputum production and experience frequent exacerbations (worsening).
Symptoms include:
- Coughing of yellow or green sputum daily
- Shortness of Breath
- Fatigue
- Chest pain
You may qualify for this no-cost clinical trial if you:
- Are 18 - 85 years of age
- Diagnosis of Bronchiectasis affecting one or more lobes
- At least 2 pulmonary exacerbations in the past 12 months
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Gonorrhea Clinical Trial
Gonorrhea is an infection caused by a bacteria spread by sexual contact and can cause serious health problems if left untreated for too long. It is important to get tested and/or treated if you think you have gonorrhea or have a partner with gonorrhea.
Symptoms include:
- Green, yellow, or white discharge from the penis or vagina
- A burning feeling in the throat or when urinating
- Pain in the pelvis or testicles
You may qualify for this no-cost clinical trial if you:
- Are at least 12 years of age
- Have a suspected gonorrhea infection
Qualified volunteers may receive at no cost:
- Study medication for gonorrhea
- Study-related care
- Reimbursement for your travel
Tesamorelin for Cognition in Aging HIV-Infected Persons Clinical Trial
This clinical trial is testing an FDA-approved injectable medication (Tesamorelin) to treat abdominal fat accumulation in patients with HIV. Abdominal fat accumulation is linked to memory and thinking difficulties, and previous studies suggest that Tesamorelin may be beneficial for cognitive function, but this has not been tested in HIV. PCR, Inc. is working with the University of California San Diego (UCSD) on this trial.
Click the link to learn more: https://clinicaltrials.ucsd.edu/trial/NCT02572323
You may qualify for this no-cost clinical trial if you:
- Are at least 40 years of age or older
- HIV-1 Infection diagnosis
- Are currently receiving a combination antiretroviral therapy (cART) regimen ≥ 12 weeks with no interruptions longer than 7 days and HIV < 500 copies/mL
- Minimum abdominal waist circumference ≥ 95cm (male) or ≥ 94cm (female)
- Other criteria may apply
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Idiopathic Pulmonary Fibrosis (IPF) Clinical Trial
IPF is a a chronic, progressive, irreversible, and usually lethal lung disease of unknown cause that occurs mostly in elderly adults.
Symptoms include:
- Worsening cough & shortness of breath
- Fatigue
- Unexplained weight loss
- Muscle & joint pain
You may qualify for this no-cost clinical trial if you:
- Are 40-85 years of age
- Have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF) within the last 3 years
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Human Immunodeficiency Virus (HIV) Clinical Trial
This clinical trial is for individuals who have tried several antiretroviral treatments; but their viral levels are no longer suppressed because of resistance, lack of access, or intolerance to medications.
You may qualify for this no-cost clinical trial if you:
- Are 12 years of age or older
- HIV +
- Currently on failing
- Antiretroviral
- Therapy (ART)
- From “RNA ≥ 500 copies/mL” to “Viral load ≥ 500 copies/mL)
- Weigh ≥ 35 kg (77.2 lbs)
Qualified volunteers may receive at no cost:
- Study medication
- Study-related care
- Reimbursement for your travel
Clostridium difficile (C. diff) Clinical Trial
Clostridium difficile is a bacteria that causes severe diarrhea and inflammation of the colon that can occur during or after taking antibiotics. This clinical trial is for the prevention of C. diff infection (CDI) recurrence. The study is to see how well ART24 (novel oral study medication) is tolerated and how well ART24 can help prevent future episodes of C. difficile infection compared to placebo.
Symptoms include:
- Watery Diarrhea 3 or more times a times a day for 2 or more days
Nausea, Dehydration, Loss of appetite
- Abdominal cramping and pain
You May qualify for this no-cost clinical trial if you:
- Are 18-75 years of age
- Are currently taking or have recently finished (within the last 6 days) taking antibiotics for a C. difficile infection
- Do not have Inflammatory Bowel Disease (IBD)
- Other criteria may apply
Qualified volunteers may receive at no cost:
-ART24 or placebo
- Study-related medication and exams at no cost
- Compensation for reasonable travel and meal expenses
Colorectal Cancer (CRC) & Advanced Neoplasia (AN) Clinical Study
This clinical study is for individuals 45-84 years of age and are scheduled to undergo a screening colonoscopy and consider as 'average risk' for colorectal cancer.
The purpose of this clinical study is to collect blood samples to better understand the biomarkers of patients with colorectal cancer and help develop a blood-based screening test. Biomarkers are biologic features found in the blood and may be related to cancer risk.
Study Includes:
- Single visit for blood sample collection prior to your scheduled colonoscopy
- Compensation for qualified participants
Health insurance and doctor referrals are not required to participate in the clinical trials & clinical studies.
Upcoming Clinical Trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Stool Collection Study for Colorectal Cancer (CRC)